Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

[Parkinson disease mortality rates in Chile: an under-reported condition].

Chaná-Cuevas P, Díaz V, Juri C.

Rev Med Chil. 2014 Mar;142(3):403-4. doi: 10.4067/S0034-98872014000300021. Spanish. No abstract available.

0

0

0

PUBMED

Gene and MicroRNA transcriptome analysis of Parkinson's related LRRK2 mouse models.

Dorval V, Mandemakers W, Jolivette F, Coudert L, Mazroui R, De Strooper B, Hébert SS.

PLoS One. 2014 Jan 10;9(1):e85510. doi: 10.1371/journal.pone.0085510.

0

0

0

PUBMED

Examining dorsal striatum in cognitive effort using Parkinson's disease and fMRI.

MacDonald AA, Seergobin KN, Tamjeedi R, Owen AM, Provost JS, Monchi O, Ganjavi H, MacDonald PA.

Ann Clin Transl Neurol. 2014 Jun;1(6):390-400. doi: 10.1002/acn3.62.

0

0

0

PUBMED

Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.

Trupp M, Jonsson P, Ohrfelt A, Zetterberg H, Obudulu O, Malm L, Wuolikainen A, Linder J, Moritz T, Blennow K, Antti H, Forsgren L.

J Parkinsons Dis. 2014;4(3):549-60. doi: 10.3233/JPD-140389.

0

0

0

PUBMED

Risk factors and prodromal markers and the development of Parkinson's disease.

Lerche S, Seppi K, Behnke S, Liepelt-Scarfone I, Godau J, Mahlknecht P, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Poewe W, Berg

J Neurol. 2014 Jan;261(1):180-7. doi: 10.1007/s00415-013-7171-0.

0

0

0

PUBMED

The effect of deep brain stimulation randomized by site on balance in Parkinson's disease.

St George RJ, Carlson-Kuhta P, Nutt JG, Hogarth P, Burchiel KJ, Horak FB.

Mov Disord. 2014 Jun;29(7):949-53. doi: 10.1002/mds.25831.

0

0

0

PUBMED

Depletion of canonical Wnt signaling components has a neuroprotective effect on midbrain dopaminergic neurons in an MPTP-induced mouse model of Parkinson's disease.

Dai TL, Zhang C, Peng F, Niu XY, Hu L, Zhang Q, Huang Y, Chen L, Zhang L, Zhu W, Ding YQ, Song NN, Liao M.

Exp Ther Med. 2014 Aug;8(2):384-390.

0

0

0

PUBMED

Chronic stress and Parkinson's disease.

Hou G, Tian R, Li J, Yuan TF.

CNS Neurosci Ther. 2014 Jan;20(1):1-2. doi: 10.1111/cns.12209. No abstract available.

0

0

0

PUBMED

Saccadic eye movements in Parkinson's disease.

Srivastava A, Sharma R, Sood SK, Shukla G, Goyal V, Behari M.

Indian J Ophthalmol. 2014 May;62(5):538-44. doi: 10.4103/0301-4738.133482. Review.

0

0

0

PUBMED

Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.

Goldman JG, Stebbins GT, Dinh V, Bernard B, Merkitch D, deToledo-Morrell L, Goetz CG.

Brain. 2014 Mar;137(Pt 3):849-59. doi: 10.1093/brain/awt360.

0

0

0

PUBMED

Association between 5-HTTLPR polymorphism and Parkinson's disease: a meta analysis.

Gao L, Gao H.

Mol Biol Rep. 2014 Sep;41(9):6071-82. doi: 10.1007/s11033-014-3484-z.

0

0

0

PUBMED

The reconstructive management of hardware-related scalp erosion in deep brain stimulation for Parkinson disease.

Gómez R, Hontanilla B.

Ann Plast Surg. 2014 Sep;73(3):291-4. doi: 10.1097/SAP.0b013e318276da63.

0

0

0

PUBMED

Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.

Dominguez-Meijide A, Villar-Cheda B, Garrido-Gil P, Sierrra-Paredes G, Guerra MJ, Labandeira-Garcia JL.

Neuropharmacology. 2014 Jan;76 Pt A:156-68. doi: 10.1016/j.neuropharm.2013.07.016.

0

0

0

PUBMED

Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.

Contu VR, Kotake Y, Toyama T, Okuda K, Miyara M, Sakamoto S, Samizo S, Sanoh S, Kumagai Y, Ohta S.

J Neurochem. 2014 Sep;130(6):826-38. doi: 10.1111/jnc.12762.

0

0

0

PUBMED

Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.

Chou VP, Ko N, Holman TR, Manning-Boğ AB.

J Vis Exp. 2014 Jan 7;(83):e50960. doi: 10.3791/50960.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy